Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2003 | 03-2002 | 03-2001 | 03-2000 | 03-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,596 | 520 | 1,059 | 1,772 | N/A |
| Receivables | 2,521 | 3,328 | 2,352 | 2,178 | N/A |
| Inventories | 5,511 | 5,284 | 3,415 | 5,297 | N/A |
| TOTAL | $10,229 | $9,447 | $7,424 | $9,765 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,236 | 1,652 | 2,042 | 2,601 | N/A |
| Intangibles | 562 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 78 | 1,224 | 1,322 | 1,217 | 0 |
| TOTAL | $1,876 | $2,876 | $3,364 | $3,818 | $N/A |
| Total Assets | $12,105 | $12,323 | $10,788 | $13,583 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 741 | 777 | 465 | 314 | 0 |
| Accrued Expenses | 1,263 | 1,169 | 1,109 | 1,062 | N/A |
| TOTAL | $2,005 | $1,950 | $1,577 | $1,376 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,005 | $1,950 | $1,577 | $1,376 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,076 | 10,063 | N/A | N/A | N/A |
| Common Shares | 13,257 | 13,097 | 13,092 | 13,077 | N/A |
| Retained earnings | -3,157 | -2,724 | -3,881 | -870 | N/A |
| TOTAL | $10,100 | $10,373 | $9,211 | $12,207 | $N/A |
| Total Liabilities And Equity | $12,105 | $12,323 | $10,788 | $13,583 | $0 |